ConquerX

ConquerX

ConquerX develops customized solutions to perform molecular profiling ten times faster and at one‐eighth of the cost of current technologies. ConquerX's EbeGen platform analyze multiple types of molecular targets in a single biological sample, at the same time and without the need for amplification. EbeGen allows the creation of a personalized biomarkers panel set for specific patients and purposes assisting the early detection of cancer and accelerating precision medicine.